TCL - 839
A Multicenter, Open-Label, Phase 3, Randomized Trial of Duvelisib vs Investigator's Choice (Gemcitabine or Bendamustine) in Relapsed/Refractory Nodal T-Cell Lymphoma with T-Follicular Helper Phenotype
Sheila Waters
Poster Presenter: Sheila Waters
